Interleukin-3 and phorbol esters induce different patterns of immediate-early gene expression in an interleukin-3 dependent cell line

Oncogene Res. 1991;6(1):1-12.

Abstract

The myeloid interleukin-3 (IL-3) dependent cell line, FDC-P1, enters the G0 stage of the cell cycle after IL-3 deprivation for 24 hr. The expression of 13 protooncogenes and immediate-early genes was compared with 4 "control" genes after the addition of either IL-3 or phorbol myristate acetate (PMA) to IL-3-deprived cells. mRNA transcripts encoding c-myc and the T-cell receptor c-gamma gene were induced to high levels only after IL-3 addition, whereas c-fos, fos-B, c-jun, jun-B, Krox-20, and Krox-24 were induced transiently only after PMA addition. The remaining genes (fra-1, p53, jun-D, c-Ha-ras, c-Ki-ras, c-raf, beta-actin, ornithine decarboxylase, and histone 2B) were detected after culture with either IL-3 or PMA. When cells were serum- and IL-3-deprived, c-fos, fos-B, c-jun, jun-B, Krox-20, and Krox-24 were detected after exposure to either serum or PMA. Moreover, culture with cycloheximide and PMA resulted in superinduction of these genes, whereas cycloheximide and IL-3 addition did not. mRNAs encoding these genes had half-lives of 10-20 min after PMA treatment, whereas that of beta-actin was longer (greater than 2 hr), suggesting that short mRNA half-lives contributed to the transient nature of these genes. Although c-fos, fos-B, c-jun, jun-B, Krox-20, and Krox-24 expression can be detected in IL-3-dependent cells after exposure to either PMA or serum, these genes were not detected after IL-3 addition, which allows cell-cycle progression. These results document the existence of IL-3 and PMA-responsive genes and demonstrate that IL-3 and protein kinase C agonists can induce distinct patterns of gene expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / biosynthesis
  • Animals
  • Bacterial Proteins*
  • Blotting, Northern
  • Cell Division / drug effects
  • Cell Line
  • Cycloheximide / pharmacology
  • DNA-Binding Proteins / biosynthesis
  • Dactinomycin / pharmacology
  • Early Growth Response Protein 1
  • Early Growth Response Protein 2
  • Gene Expression Regulation / drug effects*
  • Genes, ras / drug effects
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology
  • Half-Life
  • Histones / biosynthesis
  • Immediate-Early Proteins*
  • Interleukin-3 / pharmacology*
  • Mice
  • Ornithine Decarboxylase / biosynthesis
  • Proto-Oncogene Proteins / biosynthesis
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-jun
  • Proto-Oncogene Proteins c-myc / biosynthesis
  • Proto-Oncogene Proteins c-raf
  • RNA / biosynthesis
  • Receptors, Antigen, T-Cell / genetics*
  • Receptors, Antigen, T-Cell, gamma-delta
  • Resting Phase, Cell Cycle / drug effects
  • Tetradecanoylphorbol Acetate / pharmacology*
  • Transcription Factors / biosynthesis
  • Tumor Suppressor Protein p53 / biosynthesis

Substances

  • Actins
  • Bacterial Proteins
  • DNA-Binding Proteins
  • Early Growth Response Protein 1
  • Early Growth Response Protein 2
  • Egr1 protein, mouse
  • Egr2 protein, mouse
  • Fosb protein, mouse
  • Histones
  • Immediate-Early Proteins
  • Interleukin-3
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-jun
  • Proto-Oncogene Proteins c-myc
  • Receptors, Antigen, T-Cell
  • Receptors, Antigen, T-Cell, gamma-delta
  • Transcription Factors
  • Tumor Suppressor Protein p53
  • Dactinomycin
  • RNA
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Cycloheximide
  • Proto-Oncogene Proteins c-raf
  • Ornithine Decarboxylase
  • Tetradecanoylphorbol Acetate